Loss of maternal measles antibody during infancy in an African city

Document Type

Journal Article

Publication Date

1-1-1989

Journal

International Journal of Epidemiology

Volume

18

Issue

1

DOI

10.1093/ije/18.1.264

Abstract

Dabis F (International Health Program Office, CDC, Atlanta, GA 30333, USA), Waldman R J, Mann G F, Commenges D, Madzou G and Jones T S. Loss of maternal measles antibody during infancy in an African city. International Journal of Epidemiology 1989, 18: 264-268.Measles epidemics with 20% of the cases under nine months of age continue to occur in Brazzaville, Congo, even though measles vaccination coverage was 77% in the 12- to 23-month age group in 1986. In order to estimate the duration of passive immunity against measles, we conducted a serologic survey of infants aged 2 to 9 months. Measles antibody was measured from capillary blood with the plaque inhibition test. An antibody titre of 40 milli-International Reference Units per ml of serum (mlRU/ml) or less was defined as seronegative. Among the 252 infants studied, the proportion with detectable antibody dropped from 95.8% at 2 months of age to 48.5% at 4 months of age, and to 8.2% in the 7-8 month age group. A simple logistic model with age as the only variable provided an excellent fit to the observed values. Between the ages of 8 and 28 weeks, there was an almost steady decline of approximately 4.7% per week in the proportion of infants who were seropositive. These findings suggest that loss of maternal measles antibody during infancy might be faster than reported in other African populations. Giving measles vaccine to infants before the age of nine months currently recommended by the Expanded Programme on Immunization may be useful in some populations. Further studies of seroconversion and impact on measles are needed. © 1989 International Epidemiological Association.

Link to Full Text

Share

COinS